QSS
BLUE

Quantitative Systematic Strategies’s bluebird bio BLUE Stock Holding History

Quantitative Systematic Strategies’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-232
Closed -$263K – 283
2019
Q4 		$263K Buy
+232
New +$252K 0.04% 465
2018
Q4 		– Sell
-143
Closed -$271K – 702
2018
Q3 		$271K Buy
+143
New +$295K 0.05% 444

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Systematic Strategies's BLUE Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 232 shares — an estimated $263K sold.

Quantitative Systematic Strategies first reported a position in BLUE in Q3 2018 and held it in 2 quarters. The position peaked at $271K in Q3 2018. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • Quantitative Systematic Strategies reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 232 bluebird bio shares in Q1 2020, an estimated $263K.
  • Quantitative Systematic Strategies first reported a position in bluebird bio in Q3 2018 and held it in 2 quarters.
  • Quantitative Systematic Strategies's bluebird bio position peaked at $271K in Q3 2018.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.